腸-脳相互作用の下部および胆道障害:子供/青少年
Carlo Di Lorenzo1, Miguel Saps2, Bruno P Chumpitazi3
1Nationwide Children's Hospital, Columbus, Ohio, USA.
Gastroenterology
|February 19, 2026
まとめ
ローマV基準は,年齢ではなく,症状パターンを用いて小児腸脳相互作用障害 (DGBI) を更新しています. この改訂版では,新しい診断を導入し,子供や青少年におけるよりよい明確性のために既存の診断を精製しています.
科学分野:
- 小児胃腸内科 小児胃腸内科
- 機能的胃腸疾患 機能的な胃腸疾患
- 腸-脳相互作用研究 研究
背景:
- ローマ基準は,機能的胃腸疾患を分類するための世界的に認められた基準です.
- 以前のイテレーションは,年齢に基づくサブディビジョンに依存しており,小児の集団における診断の精度を潜在的に制限していました.
- 小児の機能性胃腸疾患の理解が進化するにつれて,診断の枠組みが更新されることが必要となる.
研究 の 目的:
- 小児の腸脳相互作用障害 (DGBI) のための更新されたローマV基準を提示する.
- 解剖学的領域と症状パターンに基づく新しい分類システムを導入する.
- 小児DGBIの診断の明確性とガイド管理を強化する.
主な方法:
- 刺激性腸症候群や機能性便秘などの状態に関する既存の基準の改正.
- 中央媒介の腹痛症候群や乳幼児苦痛症候群 (以前は乳児コリック) などの新しい診断エンティティの導入.
- 年齢に基づく分類から地域および症状に基づく分類への分類の再編成.
主要な成果:
- ローマ5条基準は,年齢に基づく分類を,腹痛,排便/腸障害,不快感障害に焦点を当てた分類に置き換える.
- 胆道疼痛症候群,機能的腹部膨胀,およびプロクトルギアフガックスなどの新しい疾患が導入されます.
- 刺激性腸症候群,機能性便秘,非抑留性 incontinenceの改訂された基準は,診断の明確性を改善します.
結論:
- 更新されたローマV基準は,小児性DGBIに対するより一貫した診断枠組みを提供します.
- 新しい分類は,子供と青少年における腸-脳相互作用障害の識別と管理を改善することを目的としています.
- 他の胃腸疾患とのDGBI併発性の認識が強調されています.
関連する概念動画
Chronic Bowel Disorders: Introduction
920
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
920
Other Disorders of Digestive System
1.7K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.7K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
732
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
732
Pharmacokinetics in Pediatric Patients: Drug Metabolism
333
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
333
Bulimia Nervosa
1.0K
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
1.0K
Gut-Brain Axis
59
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
59


